25C-NB3OMe

25C-NB3OMe is a psychedelic phenethylamine and dimethoxybenzylpiperazine derivative. It is closely related to 25C-NBOMe and is part of the larger NBOMe series of psychedelics. The compound is often used for its psychoactive effects.

Chemistry

25C-NB3OMe is a derivative of 2C-C. The full name of the chemical is 2-(4-chloro-2,5-dimethoxyphenyl)-N-(3-methoxybenzyl)ethanamine. It belongs to the NBOMe series, which includes other psychedelic phenethylamines such as 25I-NBOMe and 25B-NBOMe. The NBOMe series is characterized by the addition of a N-benzylmethoxy group to the phenethylamine backbone.

Pharmacology

The pharmacology of 25C-NB3OMe is not fully understood. However, it is known to act as a potent agonist for the 5-HT2A receptor, which is thought to be responsible for its psychedelic effects. Like other NBOMe compounds, 25C-NB3OMe is believed to be a full agonist of the 5-HT2A receptor, meaning it fully activates the receptor.

Effects

The effects of 25C-NB3OMe can vary greatly depending on the dose, set, and setting. Common effects include visual hallucinations, synesthesia, a sense of euphoria, and altered thought processes. Some users also report experiencing negative effects such as anxiety, paranoia, and uncomfortable body sensations.

Legality

The legality of 25C-NB3OMe varies by country. In many places, it is considered a controlled substance due to its similarity to other controlled psychedelics. In the United States, for example, it is classified as a Schedule I drug under the Controlled Substances Act.

Safety

The safety profile of 25C-NB3OMe is largely unknown due to the lack of scientific research. However, there have been reports of serious adverse effects and fatalities associated with its use. As with all psychedelics, it is recommended to use caution when ingesting 25C-NB3OMe.

See also

• 25I-NBOMe
• 25B-NBOMe
• 2C-C
• Psychedelic drug
• Phenethylamine